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S-P2P]-labelled alkylating decathymidylate [4-(N-2-chloroethyl)Nmethylaminobenxyl]-5’-phosphamide derivatives con- 
taining cholesterol or phenaxinium residues at their 3’-tennini were synthesized and used for allcylation of DNA within 
mammalian cells. The uptake of the cholesterol derivative by the cells and the extent of DNA alkylation are about two 
orders of magnitude higher than those of a similar alkylating derivative lacking the groups at the 3’-termini. The presence 
of the phenaxinium residue at the 3’-terminus of the oligonucleotide reagent does not improve the reagent uptake by 
the cells but drastically increases the DNA modification efficiency. 
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1. INTRODUCTION 
Oligonucleotide derivatives are considered as 
potential biologically active compounds capable of 
interfering with functions of target nucleic acids 
possessing complementary nucleotide sequences 
[ 11. Antisense oligonucleotide derivatives can be 
used to arrest translation of mRNA or to suppress 
viruses multiplication [l-7]. Recent data on the in- 
teraction of oligonucleotide derivatives with 
superhelical plasmid DNA, DNA in isolated 
chromatin and within living cells [7-l l] suggest he 
principal possibility of sequence-specific chemical 
modification of genomic DNA. The efficiency of 
oligonucleotide derivatives as reagents targeted to 
cellular nucleic acids can be increased by improv- 
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ing their ability to penetrate into cells and by 
stabilizing their complexes with the target nucleic 
acids. 
In the present paper, we report the synthesis of 
alkylating oligonucleotide derivatives bearing 
cholesterol groups facilitating the binding of the 
derivatives to the cellular membrane, and 
phenazinium groups stabilizing the complexes of 
oligonucleotides with complementary nucleic 
acids. It was found that these derivatives react with 
cellular DNA much better than similar alkylating 
derivatives lacking polyaromatic or hydrophobic 
groups. 
2. MATERIALS AND METHODS 
Chemicals and enzymes were from Sigma and Merck. 
ClRCHsNHs was obtained from Novosibirsk Institute of 
Organic Chemistry, Siberian Division of the USSR Academy of 
Sciences. [y-32P]ATP of a high specific activity (>6000 
Ci/mmol) was obtained from the Institute of Nuclear Physics, 
Uzbek SSR Academy of Sciences. Decathymidylate was syn- 
thesized by the phosphotriester method in solution 112,131. Pro- 
tected oligonucleotide was phosphorylated [14] and cholesterol 
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or amino-protected aminoethanol was coupled to the the possibility of improving oligonucleotide uptake 
3 ’ -phosphate of the oligonucleotide to yield corresponding 
3 ‘-phosphodiesters. The oligonucleotide derivatives ynthesized 
by coupling the hydrophobic groups, we synthesiz- 
were unblocked and isolated. Phenazinium was coupled to 
ed reagents I, II, and III (fig.1) and investigated 
decathymidylate, carrying an amino group at the 3 ‘-end, under their interaction with Krebs-2 ascite carcinoma 
conditions described by Zarytova et al. [15]. The cells and L-929 mouse fibroblasts. The results of 
oligonucleotide derivatives were labelled by T4 polynucleotide 
kinase-catalyzed phosphorylation with 5 ‘-[r-“P]ATP [16] and 
the experiments are represented in fig.2. The most 
ClRCHzNHz was coupled to the 5 ‘-phosphate of the derivative 
efficient binding was observed for the cholesterol 
according to Godovikova et al. (171. Details of the synthetic and derivative at 37°C. 
purification procedures will be published elsewhere. Fig.3 shows the dependence of the steady-state 
Cultivation of L-929 mice fibroblasts and Krebs-2,ascite car- 
cinoma cells was described earlier [11,18]. After treatment of Uptake 
the cells with the oligonucleotide derivatives, the cell lyzates pmolei5;10ecellS 
were analyzed by gel electrophoresis in agarose or 5-20% 
polyacrylamide gel followed by ethidium bromide staining and 
radioautography. Experiments with chromatin were carried out 
on the isolated rat liver nuclei [19]. DNA was isolated by phenol 
extraction, treated by proteinase K and ribonuclease A, and 
analyzed by gelfiltration on a Sephadex G-100 column in 7 M 
urea or by electrophoresis in 1% agarose and radioactivity 
bound with DNA was counted in a liquid scintillation system. 
3. RESULTS AND DISCUSSION 
Recent studies [l-6,11,18] have demonstrated 
that deoxyribonucleotides can penetrate 
eukaryotic cells by the adsorption and liquid en- 
docytosis mechanism [181. In order to investigate 
ClCH2CH2, 0 
0 








Fig. 1. Alkylating oligonucleotide derivatives. 
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Fig.2. Kinetics of the reagents I (1) and II (2) uptake by the 
Krebs-2 ascite carcinoma cells in RPM1 medium at different 
temperatures: (a) 5°C; (b) 2O’C; (c) 37°C. Cell concentration, 
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Fig.3. Effect of oligonucleotide derivative concentrations on 
their limit of uptake (incubation for 2 h at 37°C): 1, reagent I; 
2, reagent II; 3, reagent III. 
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Table 1 
Oligonucleotide derivative uptake by Krebs-2 ascite carcinoma cells and L-929 mice fibroblasts. 
Cells Reagent Concentration &M) 
In the medium In the cellsa 
Uptake by the cells 
(pm01 per 5 x lo6 
cells) 
Contents in the nuclei 
(pm01 per 5 x lo6 
cells) 
Krebs 2 I 0.5 0.16 0.9 0.057 
ascite II 0.5 4.0 23.5 7.68 
carcinoma III 0.5 0.13 0.7 0.11 
L-929 mice I 1.0 1.0 6.0 0.27 
fibroblasts II 2.5 15.0 90.0 3.6 
III 2.0 2.3 13.8 0.62 
‘The cell volume was assumed to be 1.1-1.2 x 10m6 ~1 [ll]. The accuracy of concentration determination was about e 15% 
The cells were incubated with the derivatives in RPM1 medium for 2 h at 37°C 
intracellular oligonucleotide concentration (after 
reaching the plateau) on the concentration of the 
derivative in the medium. It is seen that the 
cholesterol residue causes a considerable increase 
of the oligonucleotide uptake level. Phenazinium 
residue has no effect on the derivative uptake. In 
table 1, intracellular concentrations and the level 
of the oligonucleotide derivative uptake are 
shown. It is seen that all the derivatives penetrate 
the cells and reach the nucleus, the highest uptake 
level being observed for reagent II. Its concentra- 
tion within the cell is about 8 times higher than in 
the medium, and substantial amounts of the 
derivative are found in the nucleus. It is possible 
that some cholesterol-binding proteins [20] can 
take part in the delivery of cholesterol-containing 
reagent into the nucleus. From this point of view, 
interesting results were obtained in the experiments 
with chromatin in the isolated mice nuclei (table 2). 
The modificiation level of the chromatin DNA 
treated by reagent II was found to be one order of 
magnitude higher than that of DNA treated by 
reagent I under similar conditions. 
Table 2 
Extent of modification of DNA in chromatin of the isolated 
rat liver nuclei (mol of reagent per mol of nucleotides x 106) 
Reagent Concentration of Extent of 
competitor (pT)ro &m) modification 
I 18zt 4 
4 4* 8 
II 186 f 20 
17 so* 9 
Nuclei (10’ per ml) were treated with the reagents (1 PM) in a 
buffer for nuclei isolation [19] 
Electrophoresis data (not shown) indicated that 
up to 70% radioactivity was bound with the 
biopolymers. The radioactive material was found 
in DNA. Treatment of DNA with an HC104 solu- 
tion resulted in the release of DNA-bound radioac- 
tivity thus indicating that it was associated with 
DNA due to chemical modification and not due to 
reutilization of radioactive phosphate. The DNA 
modification level was determined as a specific 
DNA-bound radioactivity after it was additionally 
treated by protease, RNase and purified by gel 
filtration under denaturing conditions. When the 
cells were treated with hydrolyzed reagent 
analogue (i.e. containing OH group instead of Cl), 
no radioactivity was eluted with the cellular DNA. 
The extent of modification appeared to be 0.79 
mol per lo6 mol of nucleotides for reagent I, 54 
mol for reagent II, and 6.5 mol for reagent III. 
The increase in DNA modification efficiency for 
reagents II and III has probably been brought 
about differently. In the case of reagent II, two 
factors may play an important role: efficient bin- 
ding of the hydrophobic reagent with the cellular 
membrane and a higher affinity of cholesterol to 
chromatin, probably mediated by some 
cholesterol-binding proteins. The polyaromatic 
residue in reagent III stabilizes the complementary 
complex formed by the derivative. Therefore, the 
modification level achieved with the reagent is 
quite high despite the low uptake efficiency of this 
derivative. 
The results obtained provide evidence that the 
coupling of lipophilic membrane-anchoring groups 
to oligonucleotides facilitates the delivery of 
oligonucleotide derivatives into mammalian cells. 
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